APRIL MCGRIFF: Open Payments
NPI 1861988735 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,683 in 96 payments from 30 companies in 2025. Trend: 2023 $16 · 2024 $0 · 2025 $3,683
Food & beverage: $2,612Travel & lodging: $988Education: $84
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 6 | $1,077 |
| Abbott Laboratories | 8 | $489 |
| ABBVIE INC. | 18 | $406 |
| Janssen Biotech, Inc. | 2 | $218 |
| SK Life Science, Inc. | 8 | $186 |
| Lilly USA, LLC | 6 | $174 |
| Biogen, Inc. | 7 | $136 |
| Novo Nordisk Inc | 1 | $107 |
| UCB, Inc. | 3 | $84 |
| Axsome Therapeutics, Inc. | 4 | $77 |
Products named: Vercise, INFINITY, QULIPTA, General - DBS, Wegovy, AMYVID, TYSABRI, Briviact.
Industry payments across TX — which companies pay providers there.
